Similar Items: Feasibility Study of Combined Systemic Therapy and Carbon‐Ion Radiotherapy for Hepatocellular Carcinoma Patients
- Radiotherapy and Immunotherapy In Hepatocellular Carcinoma: Priming the Tumor Immune Microenvironment From Bench To Bedside
- Prognostic Impact of the Systemic Immune-Inflammation Index in Unresectable Hepatocellular Carcinoma Undergoing Second-Line Combination Therapy: A Multicenter Study
- Conversion therapy for advanced hepatocellular carcinoma following complete response to transarterial radioembolization combined with atezolizumab and bevacizumab
- Calculating the relative biological effectiveness of carbon ion radiotherapy by common models using measurable microdosimetric inputs
- Combining radiotherapy with CAR‐T cell therapy for solid tumors: Challenges, mechanisms, and future directions
- Association of Lipid and Inflammatory Profiles With Tumor Stage in Hepatocellular Carcinoma